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Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disorder that manifests as chronic inflammation and joint tissue
destruction. However, the etiology and pathogenesis of RA have not been fully elucidated. Here, we explored the role of the
hypoxia-inducible factors (HIFs), HIF-1a (encoded by HIF1A) and HIF-2a (encoded by EPAS1). HIF-2a was markedly up-
regulated in the intimal lining of RA synovium, whereas HIF-1a was detected in a few cells in the sublining and deep layer of
RA synovium. Overexpression of HIF-2a in joint tissues caused an RA-like phenotype, whereas HIF-1a did not affect joint
architecture. Moreover, a HIF-2a deficiency in mice blunted the development of experimental RA. HIF-2a was expressed
mainly in fibroblast-like synoviocytes (FLS) of RA synovium and regulated their proliferation, expression of RANKL (receptor
activator of nuclear factor–kB ligand) and various catabolic factors, and osteoclastogenic potential. Moreover, HIF-2a–
dependent up-regulation of interleukin (IL)-6 in FLS stimulated differentiation of TH17 cells—crucial effectors of RA
pathogenesis. Additionally, in the absence of IL-6 (Il62/2mice), overexpression of HIF-2a in joint tissues did not cause an RA
phenotype. Thus, our results collectively suggest that HIF-2a plays a pivotal role in the pathogenesis of RA by regulating FLS
functions, independent of HIF-1a.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory autoim-
mune disease that mainly targets the synovial membrane, resulting
in destruction of the joint architecture. The pathophysiology of RA
involves numerous cell types, including T cells, B cells, macrophag-
es, synoviocytes, chondrocytes, and osteoclasts, all of which
contribute to the process of RA pathogenesis [1]. T-cell–mediated
autoimmune responses play an important role in RA pathogenesis,
in which interleukin (IL)-17–producing T-helper cells (TH17) act as
crucial effectors [1,2]. RA is characterized by synovial hyperplasia
and synovitis with infiltration of immune cells. Synovial tissues
express numerous cytokines that have been directly implicated in
many immune processes of RA pathogenesis [1,3]. Additionally, an
aggressive front of hyperplastic synovium, called the pannus,
invades and destroys mineralized cartilage and bone through the
action of osteoclasts [1,3]. Synovial hyperplasia results from a
marked increase in macrophage-like and fibroblast-like synoviocytes
(FLS). Accumulating evidence indicates that activated FLS are
among the key players in RA joint destruction [4]. FLS actively
contribute to the initiation, propagation, and maintenance of
synovial inflammation through secretion of factors and direct cell–
cell interactions. For instance, cytokines and chemokines produced
by FLS attract T cells to RA synovium, and the interaction of FLS
with T cells results in activation of both cell types. FLS in the
inflamed synovium also contribute to RA pathogenesis by
producing matrix-degrading enzymes involved in cartilage destruc-
tion; RANKL (receptor activator of nuclear factor–kB ligand),
which regulates osteoclast differentiation, leading to bone erosion;
and angiogenic factors associated with blood vessel formation [4].
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Despite therapeutic advances, the etiology of RA pathogenesis has
not yet been entirely elucidated, and effective treatment of RA
remains a significant unmet medical need.
A prominent feature of the inflamed RA synovium is hypoxia
[5–7], suggesting a possible role for hypoxia-inducible factors
(HIFs) in RA pathogenesis. HIFs are members of a transcription
factor family that act as ‘‘master regulators’’ of the adaptive
response to hypoxia [8,9]. Of the three isoforms, HIF-1a (encoded
by HIF1A) and HIF-2a (encoded by EPAS1) are the most
extensively studied. HIF-1a is up-regulated in RA synovium
[10–12], where it appears to be associated with angiogenesis [5–7].
HIF-1a is also expressed in TH17 cells, where it serves to regulate
TH17/Treg balance; a lack of HIF-1a in TH17 cells impairs their
differentiation [13,14]. Additionally, loss of HIF-1a in myeloid
cells reduces the RA pathogenesis caused by K/BxN serum
transfer [15]. Although these results suggest that HIF-1a is an
important mediator of RA pathogenesis, whether HIF-1a is
sufficient to cause RA pathogenesis in vivo has not been previously
demonstrated. Most strikingly, HIF-2a, which is closely related to
HIF-1a, has not yet been investigated for a role in RA
pathogenesis. Indeed, despite many similarities between HIF-1a
and HIF-2a, these two isoforms show different sensitivity to
oxygen tension and display distinct, and sometimes opposing,
cellular activities [8,9]. Here, we present an extensive study of the
function of HIF-2a in experimental inflammatory arthritis in mice.
We also investigated whether the role of HIF-2a is independent of,
complementary to, or redundant with that of HIF-1a in the
development and pathogenesis of experimental RA. We report
here that HIF-2a is an essential catabolic regulator of RA
pathogenesis, independent of the action of HIF-1a.
Results
HIF-1a and HIF-2a Are Differentially Up-Regulated in RA
Synovium
To explore possible functions of HIFs in RA pathogenesis, we
first examined the expression pattern of HIFs by immunostaining
human RA joint sections. HIF-2a was highly expressed in the
intimal lining of human RA synovium, where other markers of
inflamed RA synovium were expressed, including IL-6, matrix
metalloproteinase (MMP)3, and MMP13 (Figure 1A). Indeed,
double immunostaining for HIF-2a and these markers revealed
their co-localization in human RA synovium (Figure 1B). HIF-2a
was also up-regulated in tartrate-resistant acid phosphatase
(TRAP)-positive osteoclasts in bone tissue and chondrocytes in
damaged cartilage, but not in the intact, undamaged part of
human RA cartilage (Figure S1A). In contrast, HIF-1a was
detected only in a few cells in the sublining and deep layer of
human RA synovium (Figure 1A). However, neither HIF-1a nor
HIF-2a was detected in human osteoarthritis (n= 10), psoriatic
arthritis (n= 2), or gouty arthritis (n= 2) synovium (Figure S1B).
These results indicate RA-specific differential up-regulation of
HIF-1a and HIF-2a in synovial tissues.
We extended these results using the collagen-induced arthritis
(CIA) model of RA in DBA/1J mice. This is a commonly used
experimental model of inflammatory joint arthritis caused by a T-
cell–dependent, antibody-mediated autoimmune response direct-
ed against cartilage type II collagen [16]. Compared with
nonimmunized (NI) control joints, joints in CIA mice exhibited
destruction typical of RA (Figure S1C–E). HIF-2a was highly up-
regulated in the region lining the CIA synovium (Figure 1C),
where it was co-localized with the RA-synovium markers, IL6,
MMP3, and MMP13 (Figure 1B). Unlike HIF-2a expression, HIF-
1a was rarely detected in the intimal lining, but was detected in
cells of the sublining and deep layer (Figure 1C). Similar to human
RA joint tissues, HIF-2a was also detected in pannus and damaged
cartilage (Figure S1F). Quantitation of relative HIF expression
levels further confirmed the marked up-regulation of HIF-2a
compared with HIF-1a in human RA and mouse CIA synovia
(Figure 1D). HIF-2a–positive cells were much more abundant in
synovial lining cells (fibroblast-like and macrophage-like synovio-
cytes) compared with sublining macrophages and endothelial cells
in blood vessels of RA synovium (Figure 1D).
Overexpression of HIF-2a, But Not HIF-1a, in Joint Tissues
Causes Experimental RA
The expression patterns of HIF-1a and HIF-2a in RA synovium
suggested differential roles of HIF isoforms. To explore the possible
in vivo functions of HIFs, we overexpressed HIF-1a or HIF-2a in the
knee joint tissues of DBA/1J mice via intra-articular (IA) injection of
Ad-Hif1a or Ad-Epas1 adenoviruses (16109 plaque-forming units
[PFUs]), respectively. Immunostaining of joint tissue sections 3 wk
after IA injection revealed that the respective adenoviruses caused
marked overexpression of HIF-1a and HIF-2a in the synovium,
cartilage, and meniscus of joint tissues (Figure 2A and B). HIF-2a
expression in joint tissues caused typical RA-like phenotypic
manifestations, including synovial hyperplasia and severe synovitis,
determined by hematoxylin and eosin (H&E) staining and scoring of
inflammation (Figure 2C and D); marked cartilage destruction,
determined by safranin-O staining and scored by Mankin’s method
(Figure 2E); pannus formation and invasion into calcified cartilage
and bone, determined by hematoxylin/safranin-O staining and
scoring (Figure 2E); and angiogenesis in the synovium, determined
by immunostaining for CD31 and counting blood vessels in synovia
of knee and ankle joints (Figure 2E). Overexpressed HIF-2a in the
synovium of Ad-Epas1–injected mice was co-localized with the RA-
synovium marker IL6, as determined by double-immunofluores-
cence microscopy (Figure S1G). In contrast to HIF-2a, HIF-1a
overexpression did not cause any changes in joint architecture,
including hallmarks of RA such as synovitis, pannus formation,
angiogenesis, and cartilage destruction (Figure 2C–E). Collectively,
Author Summary
Rheumatoid arthritis (RA) is a systemic autoimmune
disorder characterized by chronic inflammation in joint
tissues leading to destruction of cartilage and bone.
Despite some therapeutic advances, the etiology of RA
pathogenesis is not yet clear, and effective treatment of RA
remains a significant, unmet medical need. Hypoxia is a
prominent feature of inflamed tissue within RA-affected
joints, and earlier work has implicated limited involvement
of hypoxia-inducible factor (HIF)-1 a. We explored the role
of a second HIF family member, HIF-2a, in RA pathogen-
esis. We showed that HIF-2a is markedly increased in the
tissue lining the RA-affected joints. Notably and in contrast
to HIF-1a, when overexpressed in normal mouse joint
tissues, HIF-2a is sufficient to cause RA-like symptoms.
Conversely, an HIF-2a deficiency blocks the development
of experimental arthritis in mice. We discovered further
that HIF-2a regulates RA pathogenesis by modulating
various RA-associated functions of joint-specific fibroblast-
like cells, including proliferation, expression of cytokines,
chemokines, and matrix-degrading enzymes, and bone-
remodeling potential. HIF-2a also increases the ability of
these cells to promote interleukin-6–dependent differen-
tiation of TH17 cells, a known effector of RA pathogenesis.
We thus show that HIF-1a and HIF-2a have distinct roles
and act via different mechanisms in RA pathogenesis.
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these results indicate that ectopic expression of HIF-2a, but not
HIF-1a, causes typical RA-like joint destruction in mice, suggesting
distinct functions of HIF-1a and HIF-2a in RA pathogenesis.
HIF-2a Deficiency in Mice Inhibits Experimental RA
We confirmed the role of HIF-2a using HIF-2a–knockout mice
or local deletion of HIF-2a in joint tissues. We first examined HIF-
2a functions using mice with reduced expression of the Epas1
gene encoding HIF-2a. Because homozygous deletion of Epas1
(Epas12/2) is embryonic lethal [17], we used heterozygous
Epas1+/2 mice. We have previously shown that deletion of one
allele of Epas1 is sufficient to inhibit OA cartilage destruction [18].
Whereas Epas1+/2 DBA/1J mice showed reduced expression
levels of HIF-2a mRNA, HIF-1a mRNA levels were not altered in
these mice (unpublished data). Compared with wild-type (WT)
littermates, Epas1+/2 DBA/1J mice showed a significantly reduced
incidence (89.4%67.1% versus 33.2%66.5%, p= 0.0004) and
severity (2.85%60.26% versus 1.10%60.10%, p = 0.004) of CIA
on day 60 after the first injection of type II collagen (Figure 3A).
Epas1+/2 DBA/1J mice under CIA conditions also showed a
significant reduction in all the examined hallmarks of RA. These
include paw swelling and increased ankle thickness (Figure 3B),
elevated serum levels of autoantibodies against type II collagen
(Figure 3C), synovitis (Figure 3D), cartilage destruction (Figure 3E
and F), pannus formation and invasion (Figure 3E and F), and
angiogenesis in inflamed synovium (Figure 3E and F).
We further validated HIF-2a functions in CIA by locally deleting
Epas1 in joint tissues via IA injection of Ad-Cre (16109 PFU) in
Epas1fl/fl mice. Immunostaining of joint sections revealed that Ad-
Cre injection effectively reduced the elevated levels of HIF-2a
induced by CIA in joint tissues, including synovium, cartilage, and
pannus (Figure 4A). Moreover, local deletion of Epas1 in joint tissues
by Ad-Cre injection significantly inhibited RA pathogenesis by
blocking synovitis and synovial hyperplasia, pannus formation and
invasion into calcified cartilage and bone, angiogenesis in inflamed
synovium, and cartilage destruction (Figure 4B and C). These results
collectively indicate that Epas1 knockdown (Epas1+/2) or local
deletion (Ad-Cre) inhibits experimental RA in mice.
HIF-2a Modulates Immune Responses Without Affecting
Immune System Development
Next, we investigated the inhibitory mechanisms of RA
pathogenesis in Epas1+/2 DBA/1J mice by examining immune
responses. Epas1+/2 mice showed normal populations of CD4+
and CD8+ T cells in lymph nodes, as determined by flow
cytometry (Figure 5A). Flow cytometry also revealed no differences
Figure 1. HIF-1a and HIF-2a are differentially up-regulated in RA synovium. (A) Representative images of human RA synovium
immunostained for HIF-1a, HIF-2a, IL6, MMP3, and MMP13 (n=10). (B) Representative images of human RA and mouse CIA synovial sections (n= 8)
immunostained for HIF-2a and a RA synovium marker (MMP3, MMP13, or IL6) and counterstained with DAPI (triple stained). Insets are enlarged
images of double-stained cells. (C) Representative images of HIF-1a and HIF-2a immunostaining in the knee synovia of CIA and NI control DBA/1J
mice (n=10). (D) Relative expression levels of HIF-1a and HIF-2a in synovial cells (left) (n=10). HIF-2a–positive cells were counted in the indicated
compartments of RA synovium (right) (n=5). Values are means 6 SEM (*p,0.0005). Scale bar, 50 mm.
doi:10.1371/journal.pbio.1001881.g001
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in immune cell populations between WT and Epas1+/2 DBA/1J
mice, including CD4+ and CD8+ T cells in spleen and thymus;
Foxp3-expressing regulatory T cells (Treg) in lymph node, spleen,
and thymus; naı¨ve (CD44lowCD62Lhigh) and memory
(CD44highCD62Llow) CD4+ T cells in lymph node and spleen;
and B220+ B cells and CD11c+ dendritic cells in lymph node and
spleen (Figure S2A–D). Proliferation of CD4+ T cells and B220+ B
cells isolated from lymph nodes and spleens was similar between
WT and Epas1+/2 DBA/1J mice (Figure S2E and F). Additionally,
CD4+ T cells isolated from lymph nodes and spleens of Epas1+/2
mice showed a normal capacity to differentiate into TH1, TH2,
and TH17 cells, as determined by the detection of specific
cytokines (Figure 5B and Figure S2G and H).
Although immune system development was not affected in
Epas1+/2 mice, HIF-2a knockdown in these mice modulated
immune responses under CIA conditions. The population of
IL17A–producing cells in lymph nodes and spleens as well as the
levels of secreted IL17A, which plays a key role in TH17 cell
differentiation and autoimmune responses, were significantly
down-regulated under CIA conditions in Epas1+/2 mice
(Figure 5C). We further validated the effects of Epas1 knockdown
on pathogenic cytokine expression in synovial cells using a total
mixed-cell population isolated from synovial tissues of WT and
Epas1+/2 mice. mRNA levels of the pathogenic cytokines IL1b,
IL6, IL12, IL17A, IL17F, TNFa, and interferon (IFN)-c under
CIA conditions were significantly down-regulated in the total
synovial cell population isolated from Epas1+/2 mice compared
with WT littermates (Figure 5D). Conversely, IA injection of Ad-
Epas1 (16109 PFU) significantly increased mRNA levels of IL6,
IL17A, and IL17F in the total synovial cell population compared
with those in Ad-C–injected mice (Figure 5D). Collectively, our
results indicate that Epas1 knockdown in Epas1+/2 DBA/1J mice
does not alter the development pattern of the immune system, but
does significantly reduce the production of pathogenic cytokines
under CIA conditions.
HIF-2a Is Overexpressed in FLS of RA Synovium
HIF-2a is up-regulated mainly in the intimal lining of RA
synovium, which primarily consists of FLS and macrophage-like
synoviocytes [4]. We therefore examined which cell types
overexpress HIF-2a in inflamed RA synovium. Double-immuno-
fluorescence microscopy of human RA (Figure 6A) and mouse
CIA (Figure 6B) synovia revealed co-localization of HIF-2a with
FLS markers (vimentin or CD55), whereas only a subset of CD68-
positive macrophages expressed HIF-2a. We further examined
HIF-2a expression in primary cultures of the total synovial cell
Figure 2. Overexpression of HIF-2a, but not HIF-1a, in joint tissues causes an RA-like phenotype in mice. DBA/1J mice were IA-injected
with 16109 PFU of empty virus (Ad-C), Ad-Epas1, or Ad-Hif1a. After 3 wk, mice were sacrificed for further analysis. (A and B) Representative images of
HIF-1a (A) and HIF-2a (B) immunostaining in knee joint tissues. (C and D) Scoring of synovial inflammation (n= 20) (C) and representative images of
H&E staining (D). (E) Safranin-O staining and scoring of cartilage destruction (n= 20), safranin-O/hematoxylin staining and quantitation of pannus
formation (n= 15), and CD31 staining and quantitation of blood vessels (n= 15) in Ad-injected knee joints. Ca, cartilage; P, pannus. Values are means
6 SEM (*p,0.001, **p,0.0002). NS, not significant. Scale bars, 50 mm.
doi:10.1371/journal.pbio.1001881.g002
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population isolated from CIA mice; these cells consist of FLS,
macrophages, and dendritic cells, among others (Figure 6C). Most
FLS (,92%) were positive for HIF-2a staining, whereas only
,32% of macrophages were positive for HIF-2a staining
(Figure 6C). To elucidate the role of HIF-2a expression in
macrophages, we stimulated Raw264.7 cells (a murine macro-
phage cell line) with TNFa or lipopolysaccharide (LPS). Both
stimuli caused up-regulation of the inflammatory mediators
COX2 (cyclooxygenase 2) and iNOS (inducible nitric oxide
synthase), without affecting HIF-2a expression (Figure 6D). These
results collectively suggest that HIF-2a is mainly up-regulated in
FLS of RA synovium, where it may play a major role in RA
pathogenesis.
Next, we investigated the mechanisms regulating HIF-2a
expression using primary cultures of mouse FLS. The pro-
inflammatory cytokines IL1b and TNFa induced up-regulation
of HIF-2a in FLS, whereas IL6 and IL17 did not affect HIF-2a
expression (Figure 6E). A pharmacological analysis using inhibitors
of nuclear factor–kappaB (NF-kB) and mitogen-activated protein
(MAP) kinase subtypes indicated that IL1b- and TNFa-induced
Figure 3. CIA is inhibited in Epas1+/2 DBA/1J mice. (A) Incidence and severity of CIA in WT and Epas1+/2 DBA/1J mice without (NI) and with CIA
(n=20 mice per group). (B) Typical paw images on day 60 after the first immunization and ankle thickness measured with a digital thickness caliper
(n=20 mice per group). (C) Type II collagen-specific autoantibody production under NI and CIA conditions in the sera of WT and Epas1+/2 DBA/1J
mice (n= 12). (D) H&E staining and scoring of synovial inflammation (n= 10). (E) Representative images of safranin-O staining of articular cartilage,
safranin-O/hematoxylin staining of the pannus, and immunofluorescence microscopy of CD31 in knee joints of WT and Epas1+/2 DBA/1J mice
without (NI) and with CIA. (F) Quantification of results in (E). Mankin score (n=12), pannus formation (n=10), and number of blood vessels in the
synovium (n= 10). Ca, cartilage; P, pannus; M, meniscus. Values are means 6 SEM (*p,0.01, **p,0.001, ***p,0.0005). Scale bar, 50 mm.
doi:10.1371/journal.pbio.1001881.g003
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HIF-2a expression in FLS is mediated by the NF-kB pathway, but
not by the MAP kinase pathway (Figure 6F). Because hypoxia is a
prominent feature of the inflamed RA synovium [5–7], we
additionally examined the role of hypoxia in HIF-2a expression in
FLS. Mouse CIA synovium was hypoxic, as determined by
pimonidazole staining (Figure 6G). However, unlike HIF-1a
protein levels, which were markedly elevated in FLS under
hypoxic conditions, HIF-2a protein showed only minimal
accumulation under the same conditions; however, Ad-Epas1
infection under normoxic conditions caused marked expression of
HIF-2a protein (Figure 6G). Collectively, these findings suggest
that pro-inflammatory cytokines, rather than hypoxia, are the
leading cause of HIF-2a expression in FLS under CIA conditions.
HIF-2a Regulates RA-Associated FLS Functions
FLS play a crucial role in RA pathogenesis by producing
various regulatory factors [4]. We therefore explored whether up-
regulated HIF-2a in FLS modulates FLS functions and thereby
RA pathogenesis. Because increased survival and/or proliferation
of FLS contribute to synovial hyperplasia [4], we first examined
HIF-2a regulation of apoptosis and proliferation in these cells. Ad-
Epas1–mediated HIF-2a overexpression in primary cultured FLS
did not cause apoptosis or modulate apoptosis induced by an anti-
Fas antibody (unpublished data) known to cause FLS apoptosis
[4]. However, HIF-2a overexpression significantly increased
proliferation of FLS, and IL1b-induced proliferation was inhibited
in Epas1+/2 FLS (Figure 7A). Moreover, staining for the cell
Figure 4. Local deletion of Epas1 in joint tissues inhibits CIA. Epas1fl/fl mice were IA-injected with Ad-C or Ad-Cre (16109 PFU), immunized
with type II collagen (CIA) or NI, and maintained for 3 wk. (A) HIF-2a in joint tissues was detected by immunostaining (n= 10). (B) Synovitis, cartilage
destruction, pannus formation, and angiogenesis were detected by H&E staining, safranin-O staining, safranin-O/hematoxylin staining, and CD31
immunostaining, respectively. Representative images were obtained from more than 10 independent experiments. P, pannus. (C) Quantification of
synovitis, pannus formation, blood vessels in the synovium, and Mankin score (n.10). Values are means 6 SEM (*p,0.0005). Scale bar, 50 mm.
doi:10.1371/journal.pbio.1001881.g004
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proliferation marker Ki67 revealed the presence of proliferating
cells in the intimal lining of both CIA and Ad-Epas1–infected
synovia; notably, this staining was markedly reduced in Epas1+/2
DBA/1J mice (Figure 7B). Double immunostaining for HIF-2a
and Ki67 indicated that 16% and 24% of HIF-2a–positive cells
were proliferative in inflamed synovia caused by CIA and Ad-
Epas1 injection, respectively (Figure 7C).
Pannus formation and invasion into adjacent cartilage and bone
are important regulatory steps in cartilage and bone erosion,
which is mediated by the actions of osteoclasts [1,3,4]. Osteoclas-
togenesis is regulated by RANKL, which is produced by FLS and
T cells, and requires physical contact of precursor cells with
RANKL-expressing FLS or T cells in RA synovium [3,19]. We
therefore examined a possible role for HIF-2a in FLS regulation of
RANKL expression, osteoclastogenesis, and pannus formation.
HIF-2a overexpression or IL1b treatment of FLS caused
significant up-regulation of RANKL mRNA levels (Figure 7D).
Additionally, immunostaining indicated markedly increased levels
of RANKL protein in CIA synovium of WT mice, an effect that
was reduced in Epas1+/2 mice (Figure 7E). HIF-2a and RANKL
were co-localized in CIA synovium, as determined by double
immunostaining (Figure 7E). Consistent with this, TRAP staining
revealed an increase in the number of multinucleated osteoclasts in
the pannus of the bone–cartilage interface of CIA and Ad-Epas1–
infected joints of WT mice; this too was also significantly reduced
in Epas1+/2 mice (Figure 7F). The role of HIF-2a in osteoclas-
togenesis was further determined using Epas1+/2 precursor cells,
with and without HIF-2a overexpression. Osteoclastogenesis of
Epas1+/2 precursor cells was significantly reduced compared with
that of WT cells (Figure 7G). Moreover, overexpression of HIF-2a
in precursor cells by Ad-Epas1 infection enhanced osteoclastogen-
esis (Figure 7G). These results collectively support the idea that
HIF-2a–mediated production of RANKL in FLS and osteoclas-
togenesis of precursor cells contribute to cartilage and bone
erosion during HIF-2a–induced RA pathogenesis.
HIF-2a Up-Regulates Catabolic Factor Expression in FLS
FLS regulate RA pathogenesis by producing various cytokines,
chemokines, and matrix-degrading enzymes involved in inflam-
mation, chemotaxis, cartilage destruction, and bone erosion [4].
This led us to explore a possible role for HIF-2a in the expression
of these regulatory factors. Ad-Epas1–infected FLS exhibited
Figure 5. Normal immune system development and effector function of CD4+ T cells in Epas1+/2mice. (A) Representative flow cytometric
analysis of CD4+ and CD8+ T-cell populations in the lymph nodes of WT and Epas1+/2 DBA/1J mice. (B) Populations of TH1, TH2, and TH17 cells
differentiated from uncommitted CD4+ T cells of WT and Epas1+/2 DBA/1J mice. (C) IL17A-producing cells identified by flow cytometry (left), and
levels of secreted IL17A determined by ELISA (right), from lymphocytes (LN) and splenocytes (SP) of WT and Epas1+/2 DBA/1J mice (n= 8 mice per
group) under CIA conditions. (D) mRNA levels of the indicated cytokines in total knee synovial cells isolated from Epas1+/2 DBA/1J mice under CIA
conditions or in Ad-Epas1–injected mice (n= 10). The NI condition and Ad-C injection were used as controls. Values are means6 SEM (*p,0.01, **p,
0.005, ***p,0.0005).
doi:10.1371/journal.pbio.1001881.g005
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Figure 6. HIF-2a is up-regulated by pro-inflammatory cytokines in FLS of RA synovium. (A and B) Typical immunofluorescence
microscopy images of DAPI, HIF-2a, and FLS markers (vimentin and CD55) or the macrophage marker CD68 in human RA synovium (A) and mouse
CIA synovium (B). (C, Left) Primary culture of total synovial cells isolated from DBA/1J mice. DC, dendritic cells; MW, macrophages. (Center) Typical
immunofluorescence microscopy images of HIF-2a, DAPI, and vimentin or CD68. (Right) The percentage of FLS and macrophages positive for HIF-2a
staining was determined from six microscopic fields (n=4). (D) Raw264.7 cells were treated with LPS (50 ng/ml) or TNFa (50 ng/ml) for 24 h. mRNA
levels were detected by RT-PCR analysis (n= 6). (E) Primary cultured FLS were treated with IL1b (1 ng/ml), IL6 (100 ng/ml), IL17 (10 ng/ml), or TNFa
(100 ng/ml) for 24 h. mRNA levels of HIF-1a and HIF-2a were quantified by qRT-PCR (n=6). (F) FLS were treated with PD98059 (PD; 20 mM) to inhibit
ERK, SB203580 (SB; 20 mM) to inhibit p38 MAP kinase, SP600125 (SP; 20 mM) to inhibit JNK, or the indicated concentration (mM) of BAY 11-7085 (BAY)
to inhibit NF-kB. The cells were exposed to IL1b or TNFa for 24 h, and HIF-2a mRNA levels were quantified (n=6). (G) Mouse CIA synovium was
stained for the hypoxia marker pimonidazole (upper). Primary cultured FLS were maintained under hypoxic conditions or were infected with Ad-
Epas1 at an MOI of 800 for 24 h. HIF-1a and HIF-2a proteins were detected by Western blotting (lower). Values are presented as means 6 SEM (*p,
0.01, **p,0.005, ***p,0.001). Scale bar, 50 mm.
doi:10.1371/journal.pbio.1001881.g006
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significantly increased mRNA levels of matrix-degrading enzymes
(MMP3, MMP9, MMP12, MMP13, and ADAMTS4), chemo-
kines (CCL2, CCL5, CCL7, CXCL1, CXCL2, CXCL4, CXCL5,
and CXCL10), and inflammatory mediators (COX2 and iNOS)
(Figure 8A). Among the cytokines examined (IL1b, IL6, IL11,
IL12, IL17, IL21, LIF, and TNFa), both mRNA and protein levels
of IL6 and TNFa were increased in response to HIF-2a
overexpression (Figure 8B and C). Moreover, IL1b-induced up-
regulation of catabolic factors (matrix-degrading enzymes, cyto-
kines, and chemokines) was abolished by the knockdown of Epas1
with two independent small interfering RNAs (siRNAs) (Figure
S3). In contrast to the effects of HIF-2a, overexpression of HIF-1a
in FLS caused up-regulation of MMP9, IL6, COX2, and VEGF,
but not that of other factors regulated by HIF-2a (Figure 8C).
Figure 7. HIF-2a regulates FLS proliferation, RANKL expression in FLS, osteoclastogenesis, and pannus formation. (A) BrdU-
incorporation assays in FLS infected with Ad-C or Ad-Epas1 (MOI 800) (left), and FLS from WT or Epas1+/2 mice treated with 1 ng/ml of IL1b (right)
(n=6). (B) Ki67 staining in synovial sections from WT and Epas1+/2 mice without (NI) or with CIA, or from WT mice injected with Ad-C or Ad-Epas1
(MOI 800) (n= 8). (C) Double-immunofluorescence staining for HIF-2a and Ki67 in mouse CIA synovium. Ki67-positive cells among HIF-2a–
overexpressing cells were counted (n= 8). (D) RANKL mRNA levels were quantified in FLS infected with Ad-C or Ad-Epas1 (MOI 800) or treated with
1 ng/ml of IL1b (n= 10). (E) Representative images of RANKL immunostaining in the knee synovium of WT or Epas1+/2 mice without (NI) or with CIA
(Left). Typical immunofluorescence microscopy image of triple-stained CIA synovium (Right). (F) TRAP staining and counting of TRAP-positive
multinucleated cells (n= 10) in the pannus of the bone–cartilage interface in WT and Epas1+/2 mice without (NI) or with CIA, or following injection
with 16109 PFU of Ad-C or Ad-Epas1. (G) TRAP staining during in vitro osteoclastogenesis of precursor cells isolated from WT and Epas1+/2 mice or
WT precursor cells infected with Ad-C or Ad-Epas1 (800 MOI) (Left). Osteoclastogenesis was quantified by measuring the osteoclast area (n=10)
(Right). Values are means 6 SEM (*p,0.01, **p,0.001). Scale bar, 50 mm.
doi:10.1371/journal.pbio.1001881.g007
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HIF-2a–Induced Up-Regulation of IL6 in FLS Regulates
TH17 Cell Differentiation
TH17 cells are crucial effectors of RA pathogenesis [2,3], and
HIF-1a has been previously shown to regulate TH17 cell
differentiation [13,14]. For instance, enhanced HIF-1a expression
in TH17 cells positively regulates TH17 differentiation by up-
regulating RORct, an isoform of RAR-related orphan receptor
gamma [13]. We therefore examined possible functions of HIF-2a
in TH17 cell differentiation, and thereby RA pathogenesis. We first
examined mRNA levels of HIF-1a and HIF-2a during TH17 cell
differentiation. Compared with precursor CD4+ T cells, differen-
tiated TH17 cells exhibited significant down-regulation of HIF-2a
expression and significant up-regulation of HIF-1a expression
(Figure 9A). Unlike the case with HIF-1a, which enhances TH17
cell differentiation [13], overexpression of HIF-2a in precursor
CD+ T cells did not affect TH17 cell differentiation (Figure 9B),
suggesting that HIF-2a in CD4+ T cells does not directly modulate
TH17 cell differentiation.
It is well established that IL6 plays a key role in TH17 cell
differentiation [2,3]. Consistent with this, in vitro TH17 cell
differentiation was dependent on the addition of exogenous IL6
protein (Figure 9C). Given the marked overexpression of IL6 in
FLS induced by HIF-2a, we explored possible functions of HIF-
2a–regulated, FLS-derived IL6 in TH17 cell differentiation by
treating CD4+ precursor T cells with conditioned medium (CM)
prepared from Ad-C (control)- or Ad-Epas1–infected FLS. TH17
cell differentiation was evaluated by monitoring IL17A production
using an enzyme-linked immunosorbent assay (ELISA). As shown
in Figure 9C, addition of CM from Ad-Epas1–infected FLS from
WT mice induced TH17 cell differentiation, even in the absence of
exogenous IL6 protein. The specific role of IL6 in CM was
confirmed by preparing CM from FLS of Il62/2 mice or by
adding IL6 neutralizing antibody to the CM. Compared with CM
from WT FLS, CM of Ad-Epas1–infected FLS from Il62/2 mice
did not affect in vitro TH17 cell differentiation (Figure 9C).
Furthermore, addition of a neutralizing antibody against IL6, but
not TNFa, blocked stimulation of TH17 cell differentiation by the
CM of Ad-Epas1–infected FLS (Figure 9D). We additionally
confirmed TH17 cell differentiation by monitoring mRNA levels of
IL17A and IL17F using quantitative reverse transcription–
polymerase chain reaction (qRT-PCR) analysis (Figure S4).
Immunostaining of synovial sections also revealed the presence
Figure 8. HIF-2a up-regulates the expression of cytokines, chemokines, and catabolic enzymes in FLS. (A) qRT-PCR analysis (n$8) of
catabolic enzymes and chemokines in FLS infected with Ad-C (800 MOI) or with Ad-Epas1 at the indicated MOI for 24 h. (B) qRT-PCR analysis (n$8) of
mRNA levels of HIF-2a, IL6, and TNFa (Left), and ELISA of secreted IL6 and TNFa proteins (Right) in FLS infected with Ad-C (800 MOI) or with Ad-Epas1
at the indicated MOI for 24 h. (C) FLS were infected with Ad-C, Ad-Epsa1, or Ad-Hif1a (800 MOI) for 24 h. The indicated proteins were detected by
Western blotting (n= 5). Values are means 6 SEM (*p,0.01, **p,0.001).
doi:10.1371/journal.pbio.1001881.g008
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Figure 9. HIF-2a–derived IL6 in FLS regulates TH17 cell differentiation and RA pathogenesis. (A) HIF-1a and HIF-2amRNA levels in CD4
+ T
cells and differentiated TH17 cells, determined by qRT-PCR (n=5). (B) Mouse CD4
+ T cells were transfected with empty vector (EV) or Epas1-expressing
vector, and cultured under neutral or TH17-skewing conditions. TH17 cell differentiation was evaluated by monitoring IL17A production (n=4). (C)
Precursor CD4+ T cells were left untreated or were treated with antibodies against CD3 and CD28 (Abs), Mix (i.e., TGFb, IL2, and antibodies against IL4,
IFNc, and IL12), the indicated amount of IL6, or CM from WT FLS infected with Ad-C or Ad-Epas1 (Ad-E) at an MOI of 800 (left), or WT and Il62/2 FLS
infected with Ad-Epas1 (Ad-E; 800 MOI) (Right). TH17 cell differentiation was evaluated by monitoring IL17A production (n= 8). (D) TH17 cell
differentiation in the presence of Abs, Mix, or CM from WT FLS infected with Ad-Epas1 (Ad-E) and/or the indicated amounts of neutralizing antibody
against IL6 or TNFa was evaluated by monitoring IL17A (n=6). (E and F) Synovial inflammation, pannus formation, angiogenesis, and cartilage
destruction were detected by joint tissue staining and quantified in WT and Il62/2 DBA/1J mice injected with Ad-C or Ad-Epas1 (16109 PFU) or
without (NI) or with CIA. Values are means 6 SEM (*p,0.01, **p,0.001, ***p,0.0005). Scale bar, 50 mm.
doi:10.1371/journal.pbio.1001881.g009
HIF-2a in Rheumatoid Arthritis
PLOS Biology | www.plosbiology.org 11 June 2014 | Volume 12 | Issue 6 | e1001881
of IL17A-producing cells in mouse synovium infected with Ad-
Epas1 or under CIA conditions, whereas no positive immuno-
staining was observed in Ad-C–infected or NI synovium (Figure
S5A–C). Indeed, IL17A-positive cells were located in close
proximity to HIF-2a–positive cells in human RA and mouse
CIA synovia, as determined by double immunostaining (Figure
S5D).
HIF-2a Does Not Cause a RA Phenotype in Il62/2 Mice
The above results suggest that FLS-derived IL6 plays an
important role in HIF-2a regulation of experimental RA by
regulating TH17 cell differentiation. To confirm this, we investi-
gated IL6 functions in HIF-2a–induced experimental RA using
Il62/2 mice. Consistent with the inhibition of CIA by Il6 knockout
[20,21], we also observed significantly greater inhibition of
synovitis, pannus formation and invasion, cartilage destruction,
and angiogenesis in inflamed synovium under CIA conditions in
Il62/2 DBA/1J mice compared with WT littermates (Figure 9E
and F). More importantly, the development of RA-like phenotypic
manifestations, including synovitis, pannus formation and inva-
sion, cartilage destruction, and angiogenesis, induced in inflamed
synovium by IA injection of Ad-Epas1 was markedly diminished in
Il62/2 DBA/IJ mice compared with WT mice (Figure 9E and F).
Our results collectively suggest that FLS-derived IL6 plays an
important role in TH17 cell differentiation and thereby contributes
to HIF-2a regulation of experimental RA.
Discussion
Our current findings provide two novel insights into the
regulation of RA pathogenesis by HIF pathways: the catabolic
role of HIF-2a in RA pathogenesis and the differential actions of
HIF-1a and HIF-2a in this disease.
In the first case, we demonstrate an essential role for HIF-2a in
the pathogenesis of RA. Despite circumstantial evidence for the
hypoxic status of RA synovium [5–7] and increased expression of
HIF-2a in the synovial lining of human RA patients [9], little is
currently known about the role of HIF-2a in RA pathogenesis.
The results of our loss-of-function studies utilizing Epas1 knock-
down in mice (Epas1+/2) or local deletion in Epas1fl/fl mice by Ad-
Cre injection strongly support our conclusion that HIF-2a is
necessary for RA pathogenesis. This conclusion is reinforced by
the marked up-regulation of HIF-2a observed in RA synovia of
humans and mouse models of RA as well as the RA-like phenotype
revealed in gain-of-function studies involving IA injection of Ad-
Epas1. In RA joint tissues, HIF-2a is up-regulated in various
tissues, including synovium, pannus, cartilage, meniscus, and
TRAP-positive osteoclasts. IA injection of Ad-Epas1 also caused
up-regulation of HIF-2a in these tissues. Because numerous cell
types in joint tissues contribute to the process of RA pathogenesis
[1], up-regulated HIF-2a in any of these tissues could contribute to
RA pathogenesis. However, because HIF-2a levels were most
markedly increased in synovial cells, which are also the primary
targets of adenovirus infection, we characterized HIF-2a functions
in synovial tissue in the regulation of RA development. In RA
synovial tissue, HIF-2a was up-regulated in most FLS in the
synovium lining compartment, although some other cell types,
such as macrophages, also exhibited HIF-2a up-regulation.
Although we cannot rule out a contribution of these other cell
types, we were able to demonstrate that HIF-2a regulates RA-
associated FLS functions in experimental RA pathogenesis. These
include proliferation; expression of cytokines, chemokines,
and matrix-degrading enzymes; RANKL expression and osteo-
clastogenesis; IL6 production; and IL6-dependent TH17 cell
differentiation. Among these, IL6-dependent TH17 cell differen-
tiation is a crucial effector of RA pathogenesis. In this context, we
demonstrated that IL6 present in CM prepared from FLS caused
TH17 cell differentiation. Moreover, IL17A-positive cells were
located in close proximity to HIF-2a–positive cells, suggesting that
IL6 production mediated by HIF-2a in the inflamed RA synovium
affects differentiation of neighboring TH17 cells. Additional
support for this relationship is provided by our demonstration
that global deletion of Il6 abolished HIF-2a–induced RA
pathogenesis. Although it remains possible that production of
IL6 by cell types in synovial tissue besides FLS could also
contribute to the regulation of TH17 cell differentiation, estab-
lishing this definitively would likely require a conditional FLS-
specific Il6-knockout model, which, to our knowledge, has not yet
been developed.
The second novel finding of this study is that HIF-1a and HIF-
2a have distinct roles and act via different mechanisms in RA
pathogenesis. HIF-1a is up-regulated in RA synovium [10–12],
where it is associated with angiogenesis [5–7]. It has previously
been demonstrated that HIF-1a regulates RA pathogenesis by
directly modulating TH17 cell functions [13,14]. In the current
study, HIF-1a expression, in contrast to that of HIF-2a, was
detected in a small number of cells in the sublining and deep layer
of RA synovium in both humans and experimental mouse models
of RA, a result consistent with other reports [10,11]. We did not
extensively explore the underlying mechanisms of this differential
expression of HIF isoforms in the current study. However, HIF-1a
and HIF-2a show different sensitivity to oxygen tension and
display distinct, and sometimes opposing, cellular activities [8,9].
Indeed, we found in this study that sensitivities to hypoxia and to
pro-inflammatory cytokines differed between HIF-1a and HIF-2a
in FLS. These differences may reflect the differential expression
pattern of HIF-2a and HIF-2a in RA synovium. Nevertheless,
ectopic expression of HIF-1a in joint tissues by IA injection of Ad-
Hif1a did not cause an RA-like phenotype, suggesting that HIF-1a
overexpression is not sufficient to induce RA pathogenesis. In
striking contrast, HIF-2a overexpression was sufficient to activate
RA pathogenesis and did so by regulating FLS functions.
Collectively, our results suggest that HIF-2a regulates RA
pathogenesis by acting globally to modulate the RA pathogenesis
program, including angiogenesis and FLS functions, whereas HIF-
1a contributes to RA pathogenesis by modulating the effector
functions of myeloid and T cells. Moreover, the observation that
HIF-2a deficiency, which does not affect HIF-1a expression, is
sufficient to inhibit experimental RA underscores the specific roles
played by HIF-2a.
RA and OA are the most common types of joint arthritis. We
have previously shown that HIF-2a is a catabolic regulator of OA
cartilage destruction [18,22–24], demonstrating that HIF-2a
causes OA pathogenesis by up-regulating catabolic enzymes such
as MMP3 and MMP13 in chondrocytes, and further showing that
chondrocyte-specific Col2a1-Epas1 TG mice exhibit spontaneous
cartilage destruction with no evidence of synovitis [18]. Although
RA and OA phenotypes share certain features, such as cartilage
destruction, their etiology and pathogenesis are completely
different. RA and OA also differ with respect to outcomes, cell
types associated with the pathogenesis, and therapeutic approach-
es. For instance, OA is a degenerative joint disease (‘‘wear and
tear’’ arthritis) that begins with the destruction of surface articular
cartilage, subchondral bone sclerosis, and osteophyte formation in
a single joint. In this type of arthritis, mechanical stresses,
including joint instability and injury, and factors that predispose
toward OA, such as aging, are important causes of pathogenesis
[25,26]. In contrast to OA, RA is a systemic autoimmune disorder,
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which manifests as chronic inflammation that results in destruction
of cartilage and bone tissues [2–4]. The inflammatory process
initially affects a single joint, but the disease usually progresses to
affect nearly all joints [27]. Thus, our results indicate that, despite
their different etiologies and pathogenesis, both RA and OA are
regulated by HIF-2a via completely different mechanisms: HIF-2a
regulates OA pathogenesis by up-regulating matrix-degrading
catabolic enzymes in articular chondrocytes, whereas it appears to
regulate RA pathogenesis by regulating angiogenesis, various
functions of FLS, and IL6-dependent TH17 cell differentiation.
In summary, our current studies suggest that HIF-2a is an
essential catabolic regulator of RA pathogenesis that acts by
modulating various RA-associated FLS functions. Because the
etiology of RA pathogenesis has not yet been entirely elucidated
and effective treatment of RA remains a significant unmet medical
need, HIF-2a may serve as an effective therapeutic target in RA
treatment. In this context, an important question that remains to
be evaluated is whether recently developed small-molecule
inhibitors of HIF-2a [28,29] inhibit RA pathogenesis in vitro and
in vivo. Additionally, because HIF-1a and HIF-2a appear to
regulate RA pathogenesis through different mechanisms, both
HIF isoforms could be alternative therapeutic targets in the
treatment of RA disease.
Materials and Methods
Ethics Statement
The use of human materials was approved by the Institutional
Review Board of Chonnam National University Hospital and
Wonkwang University Hospital, and written informed consent was
obtained from all individuals before the operative procedure. Mice
were housed in specific pathogen-free barrier facilities and were
used in accordance with protocols approved by the Animal Care
and Ethics Committees of the Gwangju Institute of Science and
Technology.
Human Arthritic Joint Tissues
Human RA, psoriatic arthritis, gouty arthritis, and OA joint
tissues were collected from patients undergoing knee arthroplasty
(Tables S1, S2, S3) and then embedded in paraffin. All RA
patients had a median disease duration of ,6 y, high disease
activity (i.e., median DAS of 5.61), and received medications,
including a variety of disease-modifying antirheumatic drugs
(Table S1). Because joint tissues were obtained from patients
undergoing knee arthroplasty, our samples represent relatively
late-stage RA.
Mice and Experimental Arthritis
Male DBA/1J, C57BL/6, Epas1+/2, Epas1fl/fl, and Il62/2 mice
were used for experimental RA studies. The C57BL/6 strains of
Epas1+/2, Epas1fl/fl, and Il62/2 mice were described previously
[18,22]. Epas1+/2, Epas1fl/fl, and Il62/2 (C57BL/6) mice were
backcrossed against the DBA/1J strain for eight generations to
generate Epas1+/2 DBA/1J, Epas1fl/fl DBA/1J, and Il62/2 DBA/
1J mice, respectively. CIA was produced in WT and Epas1+/2
DBA/1J mice using a standard protocol [16]. Briefly, mice were
intradermally injected at the base of the tail with incomplete
Freund’s adjuvant alone (control) or Freund’s adjuvant containing
100 mg of collagen type II; a booster injection was given 21 d later.
Epas1fl/fl DBA/1J mice were IA-injected with Ad-C or Ad-Cre
(16109 PFU) on days 0, 3, and 6, followed by a booster injection
with collagen type II. Mice were maintained for an additional
2 wk. The incidence and severity of RA were evaluated on the
indicated days after the first immunization. Severity was evaluated
using a clinical score (grade 0–4) of paw swelling based on the level
of inflammation in each of the four paws [16]. Joint tissues from
mice were fixed, decalcified with 0.5 M EDTA (pH 8.0),
embedded in paraffin, and sectioned at 5-mm thickness. Synovitis
was evaluated by H&E staining of joint sections, and synovial
inflammation (grade 0–4) was scored as described by Tang et al.
[30]. The pannus in joint tissues adjacent to cartilage and bone
was visualized by H&E staining with or without safranin-O
staining of cartilage, and pannus formation was scored (grade 0–4)
as described by Tang et al. [30]. Cartilage destruction was
examined by safranin-O staining and scored using Mankin’s
method, as previously described [18,31].
Immunohistochemistry and Immunofluorescence
Microscopy
Human and mice joint tissues were sectioned at 5-mm thickness
for immunohistochemical staining. Antigen retrieval was per-
formed by incubating sections with 0.1% trypsin for 40 min at
37uC or with citrate buffer for 20 min at 95uC. The following
primary antibodies were used for immunohistochemistry: rabbit
anti–HIF-2a and rabbit anti-RANKL (Santa Cruz), rabbit anti-
MMP3 and anti-MMP13 (Abcam), goat anti-IL6 (R&D Systems),
rabbit anti-IL17A (Abcam), mouse anti-HIF-1a (Sigma), and rat
anti-CD31 (Dianova). For double-immunofluorescence labeling of
human and mouse joint tissues, the following primary antibodies
were used: rabbit anti–HIF-2a (Novus Biologicals for human
tissues and Santa Cruz for mouse tissues), rabbit anti-MMP3
(Abcam), mouse anti-MMP13 (Calbiochem, for human synovia),
rabbit anti-MMP13 (Abcam, for mouse synovia), goat anti-IL6
(R&D Systems), mouse anti-vimentin (BD Biosciences), rabbit anti-
CD55 (Santa Cruz), rabbit anti-CD68 (Abcam, for human
synovia), rat anti-CD68 (Abcam, for mouse synovia), rabbit anti-
TRAP (Santa Cruz), rabbit anti-VEGF (Santa Cruz), rabbit anti-
IL17A (Santa Cruz), rabbit anti-Ki67 (Abcam), and rabbit anti-
RANKL (Santa Cruz). Expression levels of HIF-2a in RA
synovium were quantified using Image J software. The percentage
of cells expressing HIF-2a was analyzed in synovial lining cells
(fibroblast-like and macrophage-like synoviocytes), sublining mac-
rophages, and endothelial cells [32]. Cell types were distinguished
according to their characteristic morphology and confirmed by
immunoreactivity with anti-vimentin (FLS), anti-CD68 (macro-
phages), and anti-CD31 (endothelial cells) antibodies. For immu-
nofluorescence staining of total synovial cells or FLS cultured on
coverslips, the following antibodies were used: rabbit anti–HIF-2a
(Novus Biologicals), goat anti-IL6 (R&D Systems), rabbit anti-
CD68, and mouse anti-vimentin (BD Biosciences).
FLS Culture, CM Preparation, and Proliferation Assays
Total synovial cells were isolated from knee joint synovium of
CIA mice. Synovial tissues were minced and digested in
collagenase for 4 h at 37uC. The cells were plated on coverslips
in RPMI-1640 medium and incubated for 4 d. FLS were isolated
from NI and CIA joint tissues of WT and Il62/2 mice [33]. FLS
between passage 4 and 8 were used for further analysis. Pure FLS
(.90% CD90+/,1% CD14+) were identified by flow cytometry
using antibodies against the fibroblast marker CD90 and the
macrophage marker CD14 (Abcam). For the preparation of CM,
FLS were infected with Ad-C or Ad-Epas1 at a multiplicity of
infection (MOI) of 800 for 2 h and incubated on 35-mm culture
dishes containing 1 ml of RPMI-1640 medium. CM was used to
treat CD4+ precursor T cells during differentiation into TH17
cells. FLS proliferation in culture was quantified by measuring
BrdU incorporation during DNA synthesis. Proliferating cells in
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synovial sections were identified by detecting Ki67 using an
antibody obtained from Novus Biologicals.
T-Cell Differentiation and Proliferation
CD4+ T cells from WT and Epas1+/2 mice were purified from
lymph nodes and spleens. TH cell differentiation was induced by
plating cells (26106 cells/ml) on culture dishes coated with anti-
CD3 antibody (1 mg/ml) in the presence of soluble anti-CD28
antibody (2 mg/ml) under the following TH cell-skewing condi-
tions: TH1 cells, IL12 (10 ng/ml) and anti-IL4 antibody (10 mg/
ml); TH2 cells, IL4 (20 ng/ml) and 10 mg/ml of antibodies against
IFNc and IL12; TH17 cells, tumor growth factor (TGF)-b (3 ng/
ml), IL6 (30 ng/ml), and 10 mg/ml of antibodies against IL4,
IFNc, and IL12. IL2 (100 U/ml) was added after 24 h, and cells
were cultured for 6 d. Antibodies and cytokines were purchased
from BD Biosciences or PeproTech. The cells were stimulated
with PMA (50 ng/ml), ionomycin (1 mM), and brefeldin A (1 mg/
ml; eBioscience). TH cell differentiation was evaluated by flow
cytometry after staining for intracellular cytokines and by
detecting cytokines by ELISA and qRT-PCR. Where indicated,
activated CD4+ T cells were transfected by electroporation with
empty vector or vector carrying Epas1. The cells were cultured
under neutralizing conditions (10 mg/ml of antibodies against IL4
and IFNc) or TH17 cell-skewing conditions for 4 d. The effects of
HIF-2a overexpression on skewed CD4+ T cells were evaluated by
detecting IL17A production by ELISA. For cell proliferation
assays, CD4+ T and B220+ B cells were isolated from lymph nodes
and spleens of WT and Epas1+/2 DBA/1J mice. T-cell prolifer-
ation was induced by stimulating cells with anti-CD3 antibody
(10 mg/ml), and B-cell proliferation was induced by stimulating
cells with LPS (10 mg/ml), LPS plus IL4 (5 ng/ml), or antibodies
against IgM (20 mg/ml; Jackson ImmunoResearch) and CD40
(10 mg/ml; BioLegend). Proliferation was assessed by measuring
[3H]thymidine (0.5 mCi/well) incorporation during the last 18 h of
a 72-h culture period.
Hypoxia in FLS and Joint Tissues
For detection of the hypoxic status of mouse CIA synovium,
mice immunized with type II collagen were intraperitoneally
injected with hypoxyprobe-1 (pimonidazole HCl; Hypoxyprobe
Inc.) at a dosage of 60 mg/kg body weight and sacrificed 6 h after
injection. Paraffin-embedded joint tissues were sectioned at 5-mm
thickness, and pimonidazole was detected by immunofluorescence
microscopy, according to the manufacturer’s instructions. For
hypoxic culture of mouse FLS, cells were exposed to hypoxia for
12, 18, or 24 h in a GasPak anaerobic chamber (BBL GasPak
Pouch; Becton Dickinson) at 37uC, as described previously [18].
The proportion of oxygen in each chamber was #1%.
Flow Cytometric Analysis
Leukocytes were prepared from lymph nodes draining the
inflamed joint, spleen, and thymus of NI and CIA mice. Synovial
cells were harvested by digesting synovial tissues with collagenase.
The cells were incubated with primary antibodies for 15 min at
4uC. Antibodies against CD4, CD8, CD44, Foxp3, B220, and
CD11c were purchased from eBioscience; the anti-CD62L
antibody was from BD Pharmingen. Nonspecific staining was
ascertained using isotype-matched control antibodies. TH cells
were fixed in fixation/permeabilization buffer for 30 min;
resuspended in 100 ml of permeabilization buffer; incubated for
30 min at 4uC with Alexa 488- or phycoerythrin (PE)-conjugated
anti-IFNc (eBioscience), fluorescein isothiocyanate (FITC)-conju-
gated anti-IL4, PE-conjugated anti-IL17A or isotype control
antibodies (eBioscience); and analyzed by flow cytometry using
EPICS XL and EXPO32 software (Beckman Coulter).
ELISA of Cytokines and Autoantibody Production
Representative cytokines involved in RA pathogenesis (IFNc,
TNFa, IL4, and IL17A) and produced by TH subsets were
detected using ELISA kits (eBioscience), according to the
manufacturer’s protocol. IL6 and TNFa secreted into serum-free
culture media by FLS infected with Ad-C or Ad-Epas1 were
quantified by ELISA. Collagen type II–specific antibodies were
measured by ELISA. Sera from NI and CIA mice were added into
96-well plates coated with type II collagen (5 mg/ml), incubated
overnight at 4uC, washed, and incubated for 1 h with alkaline
phosphatase-labeled monoclonal antibodies against mouse IgG1,
IgG2a, or IgG2b (Immunology Consultants Lab). Wells were
developed using p-nitrophenyl phosphate as a substrate, and the
resulting color reaction was quantified using an ELISA plate
reader.
Bone Marrow Culture, Osteoclastogenesis, and TRAP
Staining
Bone marrow cell culture, osteoclastogenesis, and TRAP
staining were performed as described previously [34]. Briefly,
bone-marrow–derived macrophages were isolated from WT or
Epas1+/2 mice, seeded in 48-well plates (46104 cells/well), and
cultured for 4 d (Ad-C and Ad-Epas1 infection in WT cells) or 5 d
(WT and Epas1+/2 precursor cells) with M-CSF (macrophage
colony stimulating factor; 30 ng/ml) and RANKL (100 ng/ml) to
induce osteoclastogenesis. The surface area of TRAP-stained
multinuclear osteoclasts containing three or more nuclei was
measured using an Osteomeasure system (Osteometrics). TRAP
activity was also determined in paraffin sections of joint tissues
from NI and CIA mice or mice IA-injected with 16109 PFU of
Ad-C or Ad-Epas1. The numbers of TRAP-positive osteoclasts and
their precursor cells were counted in a blinded fashion in all
regions of pannus-formed bone–cartilage interface and synovium
for each knee joint.
siRNA, RT-PCR, qRT-PCR, and Western Blotting
PCR primers and experimental conditions are summarized in
Table S4. Two different siRNA sequences that silenced Epas1
effectively were used in this study (Table S5). Nonsilencing,
scrambled siRNA was used as a negative control. Cells were
transfected for 6 h with siRNA using Lipofectamine 2000
(Invitrogen), and then infected with Ad-Epas1 or treated with
IL1b. In qRT-PCR, the relative levels of target mRNA were
normalized to those of glyceraldehyde 3-phosphate dehydroge-
nase. The following antibodies were used for Western blotting:
rabbit anti-MMP2, -3, -9, -12, -13, and -14 (Epitomics); rabbit
anti-ADAMTS4 (Abcam); goat anti-IL6 (R&D Systems); rabbit
anti-ADAMTS5 (Thermo Scientific); rabbit anti-iNOS, rabbit
anti-VEGF, goat anti-RANKL, and goat anti-TNFa (Santa Cruz);
and mouse anti-COX2 (Cayman Chemical).
Statistical Analysis
The nonparametric Mann–Whitney U test was used for the
analysis of data based on an ordinal grading system, such as
synovitis, pannus, and Mankin scores. For results obtained in
qRT-PCR assays, ELISAs, and analyses of blood vessel numbers,
joint thickness, TRAP-positive cells, BrdU incorporation, thymi-
dine incorporation, and apoptotic cell numbers, data were first
tested for conformation to a normal distribution using the
Shapiro–Wilk test and then were analyzed by Student’s t test
HIF-2a in Rheumatoid Arthritis
PLOS Biology | www.plosbiology.org 14 June 2014 | Volume 12 | Issue 6 | e1001881
(pair-wise comparisons) or analysis of variance (ANOVA) with post
hoc tests (multicomparison), as appropriate. Significance was
accepted at the 0.05 level of probability (p,0.05).
Supporting Information
Figure S1 Up-regulation of HIF-2a in RA joint tissues of
humans and mice. (A) Human RA bone sections were immuno-
stained for HIF-2a and TRAP, and counterstained with DAPI.
Damaged and undamaged parts of human RA cartilage were
stained for HIF-2a (n= 4). (B) HIF-2a immunostaining in
osteoarthritis (OA; n= 10), gouty arthritis (GA; n= 2), and psoriatic
arthritis (PsA; n= 2) synovial sections. (C) Clinical score in DBA/1J
mice immunized with type II collagen (CIA) or NI (n= 20 mice per
group). (D) Sections of knee and ankle joints of NI and CIA mice
obtained 6 wk after the first immunization. (Left) H&E staining;
(Right) synovial inflammation scores (n= 15). (E) Joint sections
were collected 6 wk after the first injection and stained with
safranin-O (n= 15) to detect cartilage destruction. (F) Typical
images of HIF-2a immunostaining in joint sections of DBA/1J
mice 6 wk after the first immunization (n= 15). (G) Typical image
of triple-stained (HIF-2a, IL6, and DAPI) synovial sections from
mice IA-injected with Ad-Epas1 (16109 PFU). Values are means
6 SEM. C, cartilage; S, synovium; M, meniscus; P, pannus; Sb,
subchondral bone. Scale bar, 50 mm.
(TIF)
Figure S2 Epas1 knockdown in mice (Epas1+/2) does not affect
immune system development. (A–D) Leukocytes were isolated
from the indicated tissues of naı¨ve WT and Epas1+/2 DBA/1J
mice. Cells were stained for markers of various immune cell types,
and immune cell populations were determined by flow cytometry
and quantified (n.10 mice). CD4+ helper T cells and CD8+
cytotoxic T cells (A); Foxp3-expressing regulatory T cells (Treg) (B);
naı¨ve (CD44lowCD62Lhigh) and memory (CD44highCD62Llow)
CD4+ T cells (C); B220+ B cells and CD11c+ dendritic cells (D).
(E and F) CD4+ T cells (E) and B220+ B cells (F) were isolated from
lymph nodes and spleens from WT and Epas1+/2 DBA/1J mice
(n.8 mice). Proliferation of cells cultured for 3 d in the absence or
presence of the appropriate T- or B-cell stimulants was assessed by
[3H]thymidine incorporation assays. Results are expressed as
counts per minute (CPM). (G and H) CD4+ T cells were purified
from the lymph nodes and spleens of WT and Epas1+/2 DBA/1J
mice. TH cell differentiation was induced under TH1-, TH2-, or
TH17-skewing conditions. Recombinant IL2 (100 U/ml) was
added after 24 h, and cells were cultured in complete medium
for 6 d. Cells were restimulated with PMA, ionomycin and
brefeldin A, or left untreated, and then stained for intracellular
cytokines. The indicated cytokines were detected by ELISA in
untreated cells (G) and restimulated cells (H) (n= 6). Values are
presented as means 6 SEM.
(TIF)
Figure S3 Knockdown of Epas1 by siRNA inhibits IL1b-induced
catabolic factor expression in primary culture FLS. (A and B) FLS
were left untreated (None) or were treated with 100 nM control
siRNA (C-siRNA) or the indicated amounts of two different Epas1-
specific siRNAs—siRNA-1 (A) or siRNA-2 (B)—and then were
exposed to IL1b for an additional 24 h. mRNA levels of the
indicated catabolic factors were quantified by qRT-PCR (n= 10).
Values are means 6 SEM (*p,0.05, **p,0.01, ***p,0.001
compared with C-siRNA treatment).
(TIF)
Figure S4 IL6 produced by FLS regulates TH17 cell differen-
tiation. TH17 cell differentiation was evaluated by detecting
mRNA levels of IL17A (A) and IL17F (B) (n= 6). Precursor CD4+
T cells were left untreated or were treated with antibodies against
CD3 and CD28 (Abs), Mix (i.e., TGFb, IL2, and antibodies
against IL4, IFNc, and IL12), the indicated amount of IL6, or CM
from WT FLS infected with Ad-C or Ad-Epas1 (800 MOI), or WT
and Il62/2 FLS infected with Ad-Epas1 (800 MOI). TH17 cell
differentiation was evaluated by monitoring IL17A expression (left
panels). TH17 cell differentiation in the presence of CM from WT
FLS infected with Ad-Epas1 and/or the indicated amounts of
neutralizing antibodies against IL6 or TNFa was evaluated by
monitoring IL17A (right panels). Values are means 6 SEM (*p,
0.05, **p,0.005, ***p,0.0005).
(TIF)
Figure S5 Epas1 knockdown in mice (Epas1+/2) inhibits IL17
expression. (A) CIA was produced in WT and Epas1+/2 DBA/1J
mice, and IL17 protein was detected in NI and CIA synovial
sections after 6 wk by immunohistochemistry. (B) The knee joints
of WT and Epas1+/2 DBA/1J mice were injected with Ad-C or
Ad-Epas1 (16109 PFU). After 3 wk, synovial sections were
immunostained for IL17 and counterstained with hematoxylin.
(C) IgG was used as a negative immunostaining control.
Representative images are shown (n= 6). (D) Typical images of
triple-stained (HIF-2a, IL17A, and DAPI) human RA synovium
and mouse CIA synovium (n= 6). Scale bar, 50 mm.
(TIF)
Table S1 Clinical characteristics of RA patients with synovial
biopsy.
(DOCX)
Table S2 Clinical characteristics of two patients with gouty
arthritis.
(DOCX)
Table S3 Clinical characteristics of two patients with psoriatic
arthritis.
(DOCX)
Table S4 PCR primers and conditions.
(DOCX)
Table S5 siRNA sequences.
(DOCX)
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